Jiang Zhong Pharmaceutical Co.,Ltd (SHSE:600750) agreed to acquire Jiangxi Jiang Zhong Changrun Pharmaceutical Co., Ltd./Jiangxi Jiang Zhong Changrun Pharmaceutical Co from Jiangxi Jiang Zhong Medicine Investment and Development Co., Ltd. for CNY13.5 million on November 25, 2023.